Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Garrett Brodeur

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Genes & Molecular Sequences

Anatomy

Physiology

Living Beings

Infant

Chemicals & Drugs

Concepts & Ideas

Procedures

Chromosome Mapping

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Brodeur Garrett M; Minturn Jane E; Ho Ruth; Simpson Anisha M; Iyer Radhika; Varela Carly R; Light Jennifer E; Kolla Venkatadri; Evans Audrey E
Trk receptor expression and inhibition in neuroblastomas.
Mossé Yaël P; Laudenslager Marci; Longo Luca; Cole Kristina A; Wood Andrew; Attiyeh Edward F; Laquaglia Michael J; Sennett Rachel; Lynch Jill E; Perri Patrizia; Laureys Geneviève; Speleman Frank; Kim Cecilia; Hou Cuiping; Hakonarson Hakon; Torkamani Ali; Schork Nicholas J; Brodeur Garrett M; Tonini Gian P; Rappaport Eric; Devoto Marcella; Maris John M
Identification of ALK as a major familial neuroblastoma predisposition gene.
Fujita Tomoyuki; Igarashi Jun; Okawa Erin R; Gotoh Takahiro; Manne Jayanthi; Kolla Venkatadri; Kim Jessica; Zhao Huaqing; Pawel Bruce R; London Wendy B; Maris John M; White Peter S; Brodeur Garrett M
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Garrett Brodeur (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Brodeur Garrett M; Minturn Jane E; Ho Ruth; Simpson Anisha M; Iyer Radhika; Varela Carly R; Light Jennifer E; Kolla Venkatadri; Evans Audrey E
Trk receptor expression and inhibition in neuroblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3244-50.
2008: Mossé Yaël P; Laudenslager Marci; Longo Luca; Cole Kristina A; Wood Andrew; Attiyeh Edward F; Laquaglia Michael J; Sennett Rachel; Lynch Jill E; Perri Patrizia; Laureys Geneviève; Speleman Frank; Kim Cecilia; Hou Cuiping; Hakonarson Hakon; Torkamani Ali; Schork Nicholas J; Brodeur Garrett M; Tonini Gian P; Rappaport Eric; Devoto Marcella; Maris John M
Identification of ALK as a major familial neuroblastoma predisposition gene.
Nature 2008;455(7215):930-5.
2008: Fujita Tomoyuki; Igarashi Jun; Okawa Erin R; Gotoh Takahiro; Manne Jayanthi; Kolla Venkatadri; Kim Jessica; Zhao Huaqing; Pawel Bruce R; London Wendy B; Maris John M; White Peter S; Brodeur Garrett M
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Journal of the National Cancer Institute 2008;100(13):940-9.
2008: Cole Kristina A; Attiyeh Edward F; Mosse Yael P; Laquaglia Michael J; Diskin Sharon J; Brodeur Garrett M; Maris John M
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
Molecular cancer research : MCR 2008;6(5):735-42.
2008: Schneiderman Jennifer; London Wendy B; Brodeur Garrett M; Castleberry Robert P; Look A Thomas; Cohn Susan L
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):913-8.
2008: Okawa E R; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman K A; Xhao H; Mosse Y P; White P S; Brodeur G M
Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
Oncogene 2008;27(6):803-10.
2006: Wang Qun; Diskin Sharon; Rappaport Eric; Attiyeh Edward; Mosse Yael; Shue Daniel; Seiser Eric; Jagannathan Jayanti; Shusterman Suzanne; Bansal Manisha; Khazi Deepa; Winter Cynthia; Okawa Erin; Grant Gregory; Cnaan Avital; Zhao Huaqing; Cheung Nai-Kong; Gerald William; London Wendy; Matthay Katherine K; Brodeur Garrett M; Maris John M
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Cancer research 2006;66(12):6050-62.
2005: Bagatell Rochelle; Rumcheva Pavlina; London Wendy B; Cohn Susan L; Look A Thomas; Brodeur Garrett M; Frantz Christopher; Joshi Vijay; Thorner Paul; Rao P V; Castleberry Robert; Bowman Laura C
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8819-27.
2005: Attiyeh Edward F; London Wendy B; Mossé Yael P; Wang Qun; Winter Cynthia; Khazi Deepa; McGrady Patrick W; Seeger Robert C; Look A Thomas; Shimada Hiroyuki; Brodeur Garrett M; Cohn Susan L; Matthay Katherine K; Maris John M;
Chromosome 1p and 11q deletions and outcome in neuroblastoma.
The New England journal of medicine 2005;353(21):2243-53.
2005: Ho Ruth; Minturn Jane E; Hishiki Tomoro; Zhao Huaqing; Wang Qun; Cnaan Avital; Maris John; Evans Audrey E; Brodeur Garrett M
Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor.
Cancer research 2005;65(21):9868-75.
2005: London W B; Castleberry R P; Matthay K K; Look A T; Seeger R C; Shimada H; Thorner P; Brodeur G; Maris J M; Reynolds C P; Cohn S L
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6459-65.
2005: George Rani E; London Wendy B; Cohn Susan L; Maris John M; Kretschmar Cynthia; Diller Lisa; Brodeur Garrett M; Castleberry Robert P; Look A Thomas
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6466-73.
2005: White Peter S; Thompson Patricia M; Gotoh Takahiro; Okawa Erin R; Igarashi Jun; Kok Marleen; Winter Cynthia; Gregory Simon G; Hogarty Michael D; Maris John M; Brodeur Garrett M
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
Oncogene 2005;24(16):2684-94.
2004: Sulman Erik P; White Peter S; Brodeur Garrett M
Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34.
Oncogene 2004;23(4):1014-20.
2003: Brodeur Garrett M
Neuroblastoma: biological insights into a clinical enigma.
Nature reviews. Cancer 2003;3(3):203-16.
2003: Thompson Patricia M; Gotoh Takahiro; Kok Marleen; White Peter S; Brodeur Garrett M
CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
Oncogene 2003;22(7):1002-11.
2002: Maris John M; Weiss Matthew J; Mosse Yael; Hii George; Guo Chun; White Peter S; Hogarty Michael D; Mirensky Tamar; Brodeur Garrett M; Rebbeck Timothy R; Urbanek Margrit; Shusterman Suzanne
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
Cancer research 2002;62(22):6651-8.
2002: Hogarty Michael D; Winter Cynthia L; Liu Xueyuan; Guo Chun; White Peter S; Look A Thomas; Brodeur Garrett M; Maris John M
No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
Cancer research 2002;62(22):6481-4.
2002: Ho Ruth; Eggert Angelika; Hishiki Tomoro; Minturn Jane E; Ikegaki Naohiko; Foster Patricia; Camoratto Anna Marie; Evans Audrey E; Brodeur Garrett M
Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Cancer research 2002;62(22):6462-6.
2002: Eggert Angelika; Grotzer Michael A; Ikegaki Naohiko; Liu Xing-ge; Evans Audrey E; Brodeur Garrett M
Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Cancer research 2002;62(6):1802-8.
2002: Brodeur Garrett M
Significance of intratumoral genetic heterogeneity in neuroblastomas.
Medical and pediatric oncology 2002;38(2):112-3.
2002: Eggert A; Grotzer M A; Zuzak T J; Ikegaki N; Zhao H; Brodeur G M
Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system.
European journal of cancer (Oxford, England : 1990) 2002;38(1):92-8.
2001: Goto S; Umehara S; Gerbing R B; Stram D O; Brodeur G M; Seeger R C; Lukens J N; Matthay K K; Shimada H
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Cancer 2001;92(10):2699-708.
2001: Grotzer M A; Hogarty M D; Janss A J; Liu X; Zhao H; Eggert A; Sutton L N; Rorke L B; Brodeur G M; Phillips P C
MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2425-33.
2001: Eggert A; Grotzer M A; Zhao H; Brodeur G M; Evans A E
[Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study]
Klinische Pädiatrie 2001;213(4):191-6.
2001: Mathew P; Valentine M B; Bowman L C; Rowe S T; Nash M B; Valentine V A; Cohn S L; Castleberry R P; Brodeur G M; Look A T
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.
Neoplasia (New York, N.Y.) 2001;3(2):105-9.
2001: Eggert A; Grotzer M A; Zuzak T J; Wiewrodt B R; Ho R; Ikegaki N; Brodeur G M
Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
Cancer research 2001;61(4):1314-9.
2001: Eggert A; Grotzer M A; Ikegaki N; Zhao H; Cnaan A; Brodeur G M; Evans A E
Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):689-96.
2001: Tang X X; Evans A E; Zhao H; Cnaan A; Brodeur G M; Ikegaki N
Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
Medical and pediatric oncology 2001;36(1):80-2.
2001: Hogarty M D; Maris J M; White P S; Guo C; Brodeur G M
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Medical and pediatric oncology 2001;36(1):52-5.
2001: White P S; Thompson P M; Seifried B A; Sulman E P; Jensen S J; Guo C; Maris J M; Hogarty M D; Allen C; Biegel J A; Matise T C; Gregory S G; Reynolds C P; Brodeur G M
Detailed molecular analysis of 1p36 in neuroblastoma.
Medical and pediatric oncology 2001;36(1):37-41.
2001: Maris J M; Guo C; Blake D; White P S; Hogarty M D; Thompson P M; Rajalingam V; Gerbing R; Stram D O; Matthay K K; Seeger R C; Brodeur G M
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Medical and pediatric oncology 2001;36(1):32-6.
2001: Thompson P M; Seifried B A; Kyemba S K; Jensen S J; Guo C; Maris J M; Brodeur G M; Stram D O; Seeger R C; Gerbing R; Matthay K K; Matise T C; White P S
Loss of heterozygosity for chromosome 14q in neuroblastoma.
Medical and pediatric oncology 2001;36(1):28-31.
2001: Maris J M; Guo C; White P S; Hogarty M D; Thompson P M; Stram D O; Gerbing R; Matthay K K; Seeger R C; Brodeur G M
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
Medical and pediatric oncology 2001;36(1):24-7.
2001: Evans A E; Kisselbach K D; Liu X; Eggert A; Ikegaki N; Camoratto A M; Dionne C; Brodeur G M
Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.
Medical and pediatric oncology 2001;36(1):181-4.
2001: Brodeur G M; Look A T; Shimada H; Hamilton V M; Maris J M; Hann H W; Leclerc J M; Bernstein M; Brisson L C; Brossard J; Lemieux B; Tuchman M; Woods W G
Biological aspects of neuroblastomas identified by mass screening in Quebec.
Medical and pediatric oncology 2001;36(1):157-9.
2001: Eggert A; Ikegaki N; Liu X G; Chou T T; Brodeur G M
TrkA signal transduction pathways in neuroblastoma.
Medical and pediatric oncology 2001;36(1):108-10.
2001: Thompson P M; Maris J M; Hogarty M D; Seeger R C; Reynolds C P; Brodeur G M; White P S
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Cancer research 2001;61(2):679-86.
2000: Tang X X; Zhao H; Robinson M E; Cnaan A; London W; Cohn S L; Cheung N K; Brodeur G M; Evans A E; Ikegaki N
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.
Medical and pediatric oncology 2000;35(6):656-8.
2000: Eggert A; Ho R; Ikegaki N; Liu X G; Brodeur G M
Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.
Medical and pediatric oncology 2000;35(6):623-7.
2000: Eggert A; Grotzer M A; Zuzak T J; Wiewrodt B R; Ikegaki N; Brodeur G M
Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
Medical and pediatric oncology 2000;35(6):603-7.
2000: Huang D; Rutkowski J L; Brodeur G M; Chou P M; Kwiatkowski J L; Babbo A; Cohn S L
Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo.
Medical and pediatric oncology 2000;35(6):590-2.
2000: Eggert A; Sieverts H; Ikegaki N; Brodeur G M
p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA.
Medical and pediatric oncology 2000;35(6):573-6.
2000: Eggert A; Grotzer M A; Ikegaki N; Liu X G; Evans A E; Brodeur G M
Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma.
Medical and pediatric oncology 2000;35(6):569-72.
2000: Hogarty M D; Liu X; Thompson P M; White P S; Sulman E P; Maris J M; Brodeur G M
BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.
Medical and pediatric oncology 2000;35(6):559-62.
2000: Guo C; White P S; Hogarty M D; Brodeur G M; Gerbing R; Stram D O; Maris J M
Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.
Medical and pediatric oncology 2000;35(6):544-6.
2000: Weiss M J; Guo C; Shusterman S; Hii G; Mirensky T L; White P S; Hogarty M D; Rebbeck T R; Teare D; Urbanek M; Brodeur G M; Maris J M
Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13.
Medical and pediatric oncology 2000;35(6):526-30.
2000: Hogarty M D; Liu X; Guo C; Thompson P M; Weiss M J; White P S; Sulman E P; Brodeur G M; Maris J M
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.
Medical and pediatric oncology 2000;35(6):512-5.
2000: Huang D; Rutkowski J L; Brodeur G M; Chou P M; Kwiatkowski J L; Babbo A; Cohn S L
Schwann cell-conditioned medium inhibits angiogenesis.
Cancer research 2000;60(21):5966-71.
2000: Grotzer M A; Eggert A; Zuzak T J; Janss A J; Marwaha S; Wiewrodt B R; Ikegaki N; Brodeur G M; Phillips P C
Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
Oncogene 2000;19(40):4604-10.
2000: Tang X X; Zhao H; Robinson M E; Cohen B; Cnaan A; London W; Cohn S L; Cheung N K; Brodeur G M; Evans A E; Ikegaki N
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10936-41.
2000: Eggert A; Ikegaki N; Liu X G; Brodeur G M
Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Klinische Pädiatrie 2000;212(4):200-5.
2000: Alvarado C S; London W B; Look A T; Brodeur G M; Altmiller D H; Thorner P S; Joshi V V; Rowe S T; Nash M B; Smith E I; Castleberry R P; Cohn S L
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2000;22(3):197-205.
2000: Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur G M; Himelstein B P
High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1900-8.
2000: Maris J M; Weiss M J; Guo C; Gerbing R B; Stram D O; White P S; Hogarty M D; Sulman E P; Thompson P M; Lukens J N; Matthay K K; Seeger R C; Brodeur G M
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1888-99.
2000: Eggert A; Ikegaki N; Liu X; Chou T T; Lee V M; Trojanowski J Q; Brodeur G M
Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Oncogene 2000;19(16):2043-51.
2000: Schmidt M L; Lukens J N; Seeger R C; Brodeur G M; Shimada H; Gerbing R B; Stram D O; Perez C; Haase G M; Matthay K K
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1260-8.
2000: Nickerson H J; Matthay K K; Seeger R C; Brodeur G M; Shimada H; Perez C; Atkinson J B; Selch M; Gerbing R B; Stram D O; Lukens J
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):477-86.
1999: Evans A E; Kisselbach K D; Yamashiro D J; Ikegaki N; Camoratto A M; Dionne C A; Brodeur G M
Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3594-602.
1999: Matthay K K; Villablanca J G; Seeger R C; Stram D O; Harris R E; Ramsay N K; Swift P; Shimada H; Black C T; Brodeur G M; Gerbing R B; Reynolds C P
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
The New England journal of medicine 1999;341(16):1165-73.
1999: Guo C; White P S; Weiss M J; Hogarty M D; Thompson P M; Stram D O; Gerbing R; Matthay K K; Seeger R C; Brodeur G M; Maris J M
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
Oncogene 1999;18(35):4948-57.
1999: Tang X X; Evans A E; Zhao H; Cnaan A; London W; Cohn S L; Brodeur G M; Ikegaki N
High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1491-6.
1999: DuBois S G; Kalika Y; Lukens J N; Brodeur G M; Seeger R C; Atkinson J B; Haase G M; Black C T; Perez C; Shimada H; Gerbing R; Stram D O; Matthay K K
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1999;21(3):181-9.
1999: Kong X T; Valentine V A; Rowe S T; Valentine M B; Ragsdale S T; Jones B G; Wilkinson D A; Brodeur G M; Cohn S L; Look A T
Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.
Neoplasia (New York, N.Y.) 1999;1(1):80-9.
1999: Tang X X; Brodeur G M; Campling B G; Ikegaki N
Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):455-60.
1998: Komuro H; Valentine M B; Rowe S T; Kidd V J; Makino S; Brodeur G M; Cohn S L; Look A T
Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma.
Journal of pediatric surgery 1998;33(11):1695-8.
1998: Hogarty M D; White P S; Sulman E P; Brodeur G M
Mononucleotide repeat instability is infrequent in neuroblastoma.
Cancer genetics and cytogenetics 1998;106(2):140-3.
1998: Kwiatkowski J L; Rutkowski J L; Yamashiro D J; Tennekoon G I; Brodeur G M
Schwann cell-conditioned medium promotes neuroblastoma survival and differentiation.
Cancer research 1998;58(20):4602-6.
1998: Reiter J L; Brodeur G M
MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas.
Genes, chromosomes & cancer 1998;23(2):134-40.
1998: Sulman E P; Dumanski J P; White P S; Zhao H; Maris J M; Mathiesen T; Bruder C; Cnaan A; Brodeur G M
Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
Cancer research 1998;58(15):3226-30.
1998: Tang X X; Pleasure D E; Brodeur G M; Ikegaki N
A variant transcript encoding an isoform of the human protein tyrosine kinase EPHB2 is generated by alternative splicing and alternative use of polyadenylation signals.
Oncogene 1998;17(4):521-6.
1998: Katzenstein H M; Bowman L C; Brodeur G M; Thorner P S; Joshi V V; Smith E I; Look A T; Rowe S T; Nash M B; Holbrook T; Alvarado C; Rao P V; Castleberry R P; Cohn S L
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2007-17.
1998: Matthay K K; Perez C; Seeger R C; Brodeur G M; Shimada H; Atkinson J B; Black C T; Gerbing R; Haase G M; Stram D O; Swift P; Lukens J N
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1256-64.
1998: White P S; Jensen S J; Rajalingam V; Stairs D; Sulman E P; Maris J M; Biegel J A; Wooster R; Brodeur G M
Physical mapping of the CA6, ENO1, and SLC2A5 (GLUT5) genes and reassignment of SLC2A5 to 1p36.2.
Cytogenetics and cell genetics 1998;81(1):60-4.
1997: Castleberry R P; Pritchard J; Ambros P; Berthold F; Brodeur G M; Castel V; Cohn S L; De Bernardi B; Dicks-Mireaux C; Frappaz D; Haase G M; Haber M; Jones D R; Joshi V V; Kaneko M; Kemshead J T; Kogner P; Lee R E; Matthay K K; Michon J M; Monclair R; Roald B R; Seeger R C; Shaw P J; Shuster J J
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2113-6.
1997: Woods W G; Tuchman M; Robison L L; Bernstein M; Leclerc J M; Brisson L C; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B; Brodeur G M
Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2106-12.
1997: Yamashiro D J; Liu X G; Lee C P; Nakagawara A; Ikegaki N; McGregor L M; Baylin S B; Brodeur G M
Expression and function of Trk-C in favourable human neuroblastomas.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2054-7.
1997: Maris J M; Jensen J; Sulman E P; Beltinger C P; Allen C; Biegel J A; Brodeur G M; White P S
Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?
European journal of cancer (Oxford, England : 1990) 1997;33(12):1991-6.
1997: White P S; Maris J M; Sulman E P; Jensen S J; Kyemba S M; Beltinger C P; Allen C; Kramer D L; Biegel J A; Brodeur G M
Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1957-61.
1997: Maris J M; Kyemba S M; Rebbeck T R; White P S; Sulman E P; Jensen S J; Allen C; Biegel J A; Brodeur G M
Molecular genetic analysis of familial neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1923-8.
1997: Altura R A; Maris J M; Li H; Boyett J M; Brodeur G M; Look A T
Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization.
Genes, chromosomes & cancer 1997;19(3):176-84.
1997: Jensen S J; Sulman E P; Maris J M; Matise T C; Vojta P J; Barrett J C; Brodeur G M; White P S
An integrated transcript map of human chromosome 1p35-p36.
Genomics 1997;42(1):126-36.
1997: Brodeur G M; Maris J M; Yamashiro D J; Hogarty M D; White P S
Biology and genetics of human neuroblastomas.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1997;19(2):93-101.
1997: Sulman E P; Tang X X; Allen C; Biegel J A; Pleasure D E; Brodeur G M; Ikegaki N
ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers.
Genomics 1997;40(2):371-4.
1997: Bowman L C; Castleberry R P; Cantor A; Joshi V; Cohn S L; Smith E I; Yu A; Brodeur G M; Hayes F A; Look A T
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Journal of the National Cancer Institute 1997;89(5):373-80.
1997: Brodeur G M; Nakagawara A; Yamashiro D J; Ikegaki N; Liu X G; Azar C G; Lee C P; Evans A E
Expression of TrkA, TrkB and TrkC in human neuroblastomas.
Journal of neuro-oncology 1997;31(1-2):49-55.
1997: Maris J M; Chatten J; Meadows A T; Biegel J A; Brodeur G M
Familial neuroblastoma: a three-generation pedigree and a further association with Hirschsprung disease.
Medical and pediatric oncology 1997;28(1):1-5.
1997: Vance J M; Matise T C; Wooster R; Schutte B C; Bruns G A; van Roy N; Brodeur G M; Tao Y X; Gregory S; Weith A; Vaudin M; White P
Report and abstracts of the third international workshop on human chromosome 1 mapping 1997.
Cytogenetics and cell genetics 1997;78(3-4):154-82.
1996: Kuroda H; White P S; Sulman E P; Manohar C F; Reiter J L; Cohn S L; Brodeur G M
Physical mapping of the DDX1 gene to 340 kb 5' of MYCN.
Oncogene 1996;13(7):1561-5.
1996: Stram D O; Matthay K K; O'Leary M; Reynolds C P; Haase G M; Atkinson J B; Brodeur G M; Seeger R C
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2417-26.
1996: Maris J M; Kyemba S M; Rebbeck T R; White P S; Sulman E P; Jensen S J; Allen C; Biegel J A; Yanofsky R A; Feldman G L; Brodeur G M
Familial predisposition to neuroblastoma does not map to chromosome band 1p36.
Cancer research 1996;56(15):3421-5.
1996: Maris J M; Jensen S J; Sulman E P; Beltinger C P; Gates K; Allen C; Biegel J A; Brodeur G M; White P S
Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3.
Genomics 1996;35(2):289-98.
1996: Beltinger C P; White P S; Maris J M; Sulman E P; Jensen S J; LePaslier D; Stallard B J; Goeddel D V; de Sauvage F J; Brodeur G M
Physical mapping and genomic structure of the human TNFR2 gene.
Genomics 1996;35(1):94-100.
1996: Reiter J L; Brodeur G M
High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas.
Genomics 1996;32(1):97-103.
1996: Yamashiro D J; Nakagawara A; Ikegaki N; Liu X G; Brodeur G M
Expression of TrkC in favorable human neuroblastomas.
Oncogene 1996;12(1):37-41.
1996: Weith A; Brodeur G M; Bruns G A; Matise T C; Mischke D; Nizetic D; Seldin M F; van Roy N; Vance J
Report of the second international workshop on human chromosome 1 mapping 1995.
Cytogenetics and cell genetics 1996;72(2-3):114-44.
1995: Ikegaki N; Tang X X; Liu X G; Biegel J A; Allen C; Yoshioka A; Sulman E P; Brodeur G M; Pleasure D E
Molecular characterization and chromosomal localization of DRT (EPHT3): a developmentally regulated human protein-tyrosine kinase gene of the EPH family.
Human molecular genetics 1995;4(11):2033-45.
1995: Manohar C F; Salwen H R; Brodeur G M; Cohn S L
Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
Genes, chromosomes & cancer 1995;14(3):196-203.
1995: Shimada H; Stram D O; Chatten J; Joshi V V; Hachitanda Y; Brodeur G M; Lukens J N; Matthay K K; Seeger R C
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Journal of the National Cancer Institute 1995;87(19):1470-6.
1995: Maris J M; White P S; Beltinger C P; Sulman E P; Castleberry R P; Shuster J J; Look A T; Brodeur G M
Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
Cancer research 1995;55(20):4664-9.
1995: Tang X X; Biegel J A; Nycum L M; Yoshioka A; Brodeur G M; Pleasure D E; Ikegaki N
cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain.
Genomics 1995;29(2):426-37.
1995: Beltinger C P; White P S; Sulman E P; Maris J M; Brodeur G M
No CDKN2 mutations in neuroblastomas.
Cancer research 1995;55(10):2053-5.
1995: Nakagawara A; Milbrandt J; Muramatsu T; Deuel T F; Zhao H; Cnaan A; Brodeur G M
Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Cancer research 1995;55(8):1792-7.
1995: Morris J A; Shcochat S J; Smith E I; Look A T; Brodeur G M; Cantor A B; Castleberry R P
Biological variables in thoracic neuroblastoma: a Pediatric Oncology Group study.
Journal of pediatric surgery 1995;30(2):296-302; discussion 302-3.
1995: Nakagawara A; Liu X G; Ikegaki N; White P S; Yamashiro D J; Nycum L M; Biegel J A; Brodeur G M
Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2).
Genomics 1995;25(2):538-46.
1994: Nakagawara A; Azar C G; Scavarda N J; Brodeur G M
Expression and function of TRK-B and BDNF in human neuroblastomas.
Molecular and cellular biology 1994;14(1):759-67.
1994: Dracopoli N C; Bruns G A; Brodeur G M; Landes G M; Matise T C; Seldin M F; Vance J M; Weith A
Report and abstracts of the First International Workshop on Human Chromosome 1 Mapping 1994. Bethesda, Maryland, March 25-27, 1994.
Cytogenetics and cell genetics 1994;67(3):144-65.
1994: Hiemstra J L; Schneider S S; Brodeur G M
High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.
Progress in clinical and biological research 1994;385():51-7.
1994: Cheng J M; Hiemstra J L; Schneider S S; Kaufman B A; Naumova A; Cheung N K; Cohn S L; Diller L; Sapienza C; Brodeur G M
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Progress in clinical and biological research 1994;385():43-9.
1994: Brodeur G M; Pritchard J; Berthold F; Carlsen N L; Castel V; Castelberry R P; De Bernardi B; Evans A E; Favrot M; Hedborg F
Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.
Progress in clinical and biological research 1994;385():363-9.
1994: White P S; Fujimori M; Marshall H N; Kaufman B A; Brodeur G M
Characterization of the region of consistent deletion within 1p36 in neuroblastomas.
Progress in clinical and biological research 1994;385():3-9.
1994: Azar C G; Scavarda N J; Nakagawara A; Brodeur G M
Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
Progress in clinical and biological research 1994;385():169-75.
1994: Nakagawara A; Arima-Nakagawara M; Azar C G; Scavarda N J; Brodeur G M
Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma.
Progress in clinical and biological research 1994;385():155-61.
1993: Brodeur G M; Pritchard J; Berthold F; Carlsen N L; Castel V; Castelberry R P; De Bernardi B; Evans A E; Favrot M; Hedborg F
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1466-77.
1993: Kaufman B A; White P S; Brodeur G
A complex single strand conformational polymorphism (SSCP) in the tumor necrosis factor receptor 2 (TNFR2) gene on chromosome 1p36.2.
Human molecular genetics 1993;2(6):824.
1993: Fujimori M; White P S; Marshall H N; Brodeur G M
Simple sequence repeat polymorphism in the cartilage matrix protein (CRTM) gene at 1p35.
Human molecular genetics 1993;2(6):824.
1993: Cheng J M; Hiemstra J L; Schneider S S; Naumova A; Cheung N K; Cohn S L; Diller L; Sapienza C; Brodeur G M
Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Nature genetics 1993;4(2):191-4.
1993: White P S; Kaufman B A; Marshall H N; Brodeur G M
Use of the single-strand conformation polymorphism technique to detect loss of heterozygosity in neuroblastoma.
Genes, chromosomes & cancer 1993;7(2):102-8.
1993: Joshi V V; Cantor A B; Brodeur G M; Look A T; Shuster J J; Altshuler G; Larkin E W; Holbrook C T; Silverman J F; Norris H T
Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group.
Cancer 1993;71(10):3173-81.
1993: Nakagawara A; Arima-Nakagawara M; Scavarda N J; Azar C G; Cantor A B; Brodeur G M
Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
The New England journal of medicine 1993;328(12):847-54.
1993: Biegel J A; White P S; Marshall H N; Fujimori M; Zackai E H; Scher C D; Brodeur G M; Emanuel B S
Constitutional 1p36 deletion in a child with neuroblastoma.
American journal of human genetics 1993;52(1):176-82.
1992: Schneider S S; Hiemstra J L; Zehnbauer B A; Taillon-Miller P; Le Paslier D L; Vogelstein B; Brodeur G M
Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma.
Molecular and cellular biology 1992;12(12):5563-70.
1992: Brodeur G M; Azar C; Brother M; Hiemstra J; Kaufman B; Marshall H; Moley J; Nakagawara A; Saylors R; Scavarda N
Neuroblastoma. Effect of genetic factors on prognosis and treatment.
Cancer 1992;70(6 Suppl):1685-94.
1992: Brodeur G M; Nakagawara A
Molecular basis of clinical heterogeneity in neuroblastoma.
The American journal of pediatric hematology/oncology 1992;14(2):111-6.
1992: Fong C T; White P S; Peterson K; Sapienza C; Cavenee W K; Kern S E; Vogelstein B; Cantor A B; Look A T; Brodeur G M
Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
Cancer research 1992;52(7):1780-5.
1992: Nakagawara A; Arima M; Azar C G; Scavarda N J; Brodeur G M
Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Cancer research 1992;52(5):1364-8.
1992: Moley J F; Brother M B; Fong C T; White P S; Baylin S B; Nelkin B; Wells S A; Brodeur G M
Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Cancer research 1992;52(4):770-4.
1992: Moley J F; Wallin G K; Brother M B; Kim M; Wells S A; Brodeur G M
Oncogene and growth factor expression in MEN 2 and related tumors.
Henry Ford Hospital medical journal 1992;40(3-4):284-8.
1991: Brodeur G M; Moley J F
Biology of tumors of the peripheral nervous system.
Cancer metastasis reviews 1991;10(4):321-33.
1991: Saylors R L; Sidransky D; Friedman H S; Bigner S H; Bigner D D; Vogelstein B; Brodeur G M
Infrequent p53 gene mutations in medulloblastomas.
Cancer research 1991;51(17):4721-3.
1991: Brodeur G M; Saylors R L
Neuroblastoma, retinoblastoma, and brain tumors in children.
Current opinion in oncology 1991;3(3):485-96.
1991: Look A T; Hayes F A; Shuster J J; Douglass E C; Castleberry R P; Bowman L C; Smith E I; Brodeur G M
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):581-91.
1991: Moley J F; Brother M B; Wells S A; Spengler B A; Biedler J L; Brodeur G M
Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.
Cancer research 1991;51(6):1596-9.
1991: Schneider S S; Zehnbauer B A; Vogelstein B; Brodeur G M
Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas.
Progress in clinical and biological research 1991;366():71-6.
1991: Azar C; Scavarda N J; Reynolds C P; Brodeur G M
Multiple defects of the nerve growth factor receptor in human neuroblastomas.
Progress in clinical and biological research 1991;366():219-26.
1990: Cohn S L; Salwen H; Quasney M W; Ikegaki N; Cowan J M; Herst C V; Kennett R H; Rosen S T; DiGiuseppe J A; Brodeur G M
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Oncogene 1990;5(12):1821-7.
1990: Azar C G; Scavarda N J; Reynolds C P; Brodeur G M
Multiple defects of the nerve growth factor receptor in human neuroblastomas.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(9):421-8.
1990: Brodeur G M
Neuroblastoma--clinical applications of molecular parameters.
Brain pathology (Zurich, Switzerland) 1990;1(1):47-54.
1990: Wasson J C; Saylors R L; Zeltzer P; Friedman H S; Bigner S H; Burger P C; Bigner D D; Look A T; Douglass E C; Brodeur G M
Oncogene amplification in pediatric brain tumors.
Cancer research 1990;50(10):2987-90.
1990: Brodeur G M
Neuroblastoma: clinical significance of genetic abnormalities.
Cancer surveys 1990;9(4):673-88.
1989: Brodeur G M
Clinical significance of genetic rearrangements in human neuroblastomas.
Clinical chemistry 1989;35(7 Suppl):B38-42.
1989: Fong C T; Dracopoli N C; White P S; Merrill P T; Griffith R C; Housman D E; Brodeur G M
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3753-7.
1988: Brodeur G M; Seeger R C; Barrett A; Berthold F; Castleberry R P; D'Angio G; De Bernardi B; Evans A E; Favrot M; Freeman A I
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1874-81.
1988: Friedman H S; Burger P C; Bigner S H; Trojanowski J Q; Brodeur G M; He X M; Wikstrand C J; Kurtzberg J; Berens M E; Halperin E C
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.
The American journal of pathology 1988;130(3):472-84.
1988: Brodeur G M; Fong C T; Morita M; Griffith R; Hayes F A; Seeger R C
Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas.
Progress in clinical and biological research 1988;271():3-15.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Garrett Brodeur

Research Profile (preview)

Disorders

Genes & Molecular Sequences

Anatomy

Physiology

Living Beings

Chemicals & Drugs

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Garrett Brodeur (preview)

All Publications